Literature DB >> 11054217

Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin.

H Partsch1, W Blättler.   

Abstract

OBJECTIVE: The purpose of this randomized controlled trial was to evaluate the benefits of compression and walking exercises in comparison with bed rest in the acute stage of proximal deep venous thrombosis (DVT).
METHODS: Forty-five patients with proximal DVT that was proved with compression ultrasound scan or phlebography were randomized into three groups. Group A consisted of 15 patients who received inelastic compression bandages (Unna boots on the lower leg, adhesive bandages on the thigh), and group B consisted of 15 patients who received thigh-length compression stockings, class II. Group C consisted of 15 patients who underwent bed rest and no compression. All patients received dalteparin, 200 IU/kg per body weight, subcutaneously every 24 hours. The clinical characteristics of the three groups were comparable. Primary end points were the reduction of pain assessed daily with the Visual Analogue Scale and the Lowenberg test, the reduction of leg circumference at the ankle and calf levels, and the improvement of clinical scores. The daily walking distance was measured with a pedometer. Safety parameters were ventilation-perfusion scans and duplex ultrasound scans performed on days 0 and 9.
RESULTS: The daily walking distance was between 600 and 12,000 m in the compression groups and averaged 66 m in the bed rest group. The pain level showed a statistically significant reduction starting after the second day in the compression groups (A and B) and after 9 days in the bed rest group C (P <.05). The same was true for the measurement of leg circumference. Improvement of the clinical scores was significantly better in the compression groups compared with the bed rest group (P <.01). There was no significant difference concerning the occurrence of new pulmonary emboli and regression of thrombus diameter. Progression of thrombi in the femoral vein was greater and occurred more frequently in the bed rest group than in the other two groups (P = not significant).
CONCLUSION: Mobile patients with acute proximal DVT treated with low molecular weight heparin should be encouraged to walk with compression bandages or medical compression stockings. The rate of resolution of pain and swelling is significantly faster when the patient ambulates with compression. The risk of pulmonary embolism is not significantly increased by this approach.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054217     DOI: 10.1067/mva.2000.110352

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  24 in total

Review 1.  [Emergencies in phlebology].

Authors:  F Pannier; E Rabe
Journal:  Hautarzt       Date:  2004-06       Impact factor: 0.751

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  [Treatment of postoperative thrombosis].

Authors:  L-C Linke
Journal:  Orthopade       Date:  2009-09-06       Impact factor: 1.087

Review 4.  Compression therapy for prevention of post-thrombotic syndrome.

Authors:  Diebrecht Appelen; Eva van Loo; Martin H Prins; Martino Ham Neumann; Dinanda N Kolbach
Journal:  Cochrane Database Syst Rev       Date:  2017-09-26

Review 5.  [Diagnostic workup and therapy of acute venous diseases].

Authors:  T Silber; K Schweinzer; A Strölin
Journal:  Hautarzt       Date:  2017-08       Impact factor: 0.751

6.  Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis.

Authors:  Elham E Amin; Ingrid M Bistervels; Karina Meijer; Lidwine W Tick; Saskia Middeldorp; Guy Mostard; Marlène van de Poel; Erik H Serné; Hans M Otten; Edith M Klappe; Manuela A Joore; Hugo Ten Cate; Marije Ten Wolde; Arina J Ten Cate-Hoek
Journal:  Blood       Date:  2018-09-20       Impact factor: 22.113

7.  [Venous thromboembolism prophylaxis for urological operations].

Authors:  G Lümmen; C Fischer
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

8.  Does supervised exercise after deep venous thrombosis improve recanalization of occluded vein segments? A randomized study.

Authors:  Nazim Isma; Ellinor Johanssson; Anna Björk; Ola Björgell; Fredrik Robertson; Ingrid Mattiasson; Anders Gottsäter; Bengt Lindblad
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

9.  Daily use of a muscle pump activator device reduces duration of hospitalization and improves early graft outcomes post-kidney transplantation: A randomized controlled trial.

Authors:  Wen Xie; Max A Levine; Shahid Aquil; Katharine Pacoli; Rafid Al-Ogaili; Patrick P Luke; Alp Sener
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

10.  The treatment of deep vein thrombosis in the pelvis and leg.

Authors:  Viola Hach-Wunderle; Markus Düx; Max Zegelman; Anja Hoffmann; Florian Präve; Wolfgang Hach
Journal:  Dtsch Arztebl Int       Date:  2008-01-07       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.